Posts by: Marta Figueiredo

Marta Figueiredo

Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.

March 25, 2020March 25, 2020

Berotralstat Lowers Rate of HAE Attacks and Possibly Their Severity, Trial Reports

News

Preventive treatment with berotralstat (BCX7353) significantly lowered the number of swelling attacks — including those needing treatment — and the rates of standard on-demand therapy use in people with hereditary ... Read more

January 3, 2019January 8, 2019

Simple Diagnostic Test for Hereditary Angioedema Detects Mutations Missed by Current Methods

News, Recently Published

Researchers have developed a more cost-effective supporting diagnostic test for hereditary angioedema (HAE) to detect genetic changes that are otherwise missed by current standard methods. The study, “Gene mapping strategy for ... Read more

November 29, 2018November 29, 2018

Therapies Reduce HAE Attacks, but Cost Too Much, Review Board Says

News

Long-term prevention with human formulations of the C1 esterase inhibitor — Cinryze or Haegarda — safely and effectively reduces the number of acute attacks in people with hereditary angioedema (HAE), but the ... Read more

June 21, 2018

First Case of Food-dependent, Exercise-induced Angioedema Identified in Case Study

News

Researchers reported the first case of exercise-induced angioedema that is dependent on food in a new case study from Israel. The report, “A case of food-dependent exercise-induced angioedema,” appeared ... Read more

June 14, 2018June 14, 2018

Food Intolerance, Not Allergies, Seen as Likely Cause of Angioedema Attacks in Study

News

Food may trigger angioedema attacks through an intolerance — rather than an allergic — reaction, according to a small study published in the Orphanet Journal of Rare Diseases. In ... Read more

April 17, 2018April 17, 2018

Xolair Improves Quality of Life in Chronic Idiopathic Urticaria Patients with Angioedema, Study Says

News

In a Phase 3 clinical trial in Germany, the therapy Xolair (omalizumab) was shown to improve the quality of life and psychological well-being of chronic idiopathic urticaria (CIU) patients ... Read more

March 6, 2018March 6, 2018

Routine Haegarda Use to Prevent Hereditary Angioedema Attacks Improves Anxiety, Productivity, Study Finds

News

Subcutaneous Haegarda as a routine prevention for attacks of hereditary angioedema (HAE) significantly improves patients’ quality of life, such as lower anxiety levels and increased productivity at work, researchers found. ... Read more

Pin It on Pinterest